Brief: Genmab To Buy Merus For USD 8.0 Billion
Sept 29 (Reuters) - Genmab A/S GMAB.CO: GENMAB TO ACQUIRE MERUS, EXPANDING LATE-STAGE PIPELINE AND ACCELERATING INTO A WHOLLY OWNED MODEL GENMAB A/S - TO BUY MERUS FOR USD 8.0 BILLION GENMAB A/S - DEAL EXPECTED TO BE ACCRETIVE TO EBITDA BY 2029 GENMAB A/S - USD 97.00 PER SHARE REPRESENTS 41% PREMIUM OVER CLOSING PRICE Source text: ID:nGNXbNxYqj Further company coverage: GMAB.CO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos